Fingerprint
Dive into the research topics of 'Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program
Raushan T. Kurmasheva, Melissa Sammons, Edward Favours, Jianwrong Wu, Dias Kurmashev, Katherine Cosmopoulos, Heike Keilhack, Christine R. Klaus, Peter J. Houghton, Malcolm A. Smith
Research output: Contribution to journal › Article › peer-review
77
Scopus
citations